RVMD ▲ +0.8% - Revolution Medicines, Inc.
$RVMD - Revolution Medicines Presents Overall Survival Data for RASONQUE™ (daraxonrasib) Across Subgroups in Previously Treated Metastatic Pancreatic Cancer at ESMO 2026
23-OCT-2026 07:30 AM ET
Share this post
More filings for $RVMD
RVMD ▼ -1.2% - Revolution Medicines, Inc.Oct 21, 2026RVMD ▲ +0.7% - Revolution Medicines, Inc.Oct 20, 2026RVMD ▼ -6.3% - Revolution Medicines, Inc.Oct 8, 2026RVMD ▼ -6.3% - Revolution Medicines, Inc.Oct 8, 2026RVMD ▲ +0.4% - Revolution Medicines, Inc.Oct 5, 2026RVMD ▼ -0.6% - Revolution Medicines, Inc.Sep 15, 2026
View full $RVMD filing history →💬 Comments
Loading comments…
Leave a comment